Ninlaro Description

NINLARO 2.3 mg hard capsule: Light pink, size 4, marked "Takeda" on the cap and "2.3 mg" on the body with black ink.
Each hard capsule contains ixazomib citrate equivalent to 2.3 mg of ixazomib (as 3.3 mg of ixazomib citrate).
NINLARO 3 mg hard capsule: Light grey, size 4, marked "Takeda" on the cap and "3 mg" on the body with black ink.
Each hard capsule contains ixazomib citrate equivalent to 3 mg of ixazomib (as 4.3 mg of ixazomib citrate).
NINLARO 4 mg hard capsule: Light orange, size 3, marked "Takeda" on the cap and "4 mg" on the body with black ink.
Each hard capsule contains ixazomib citrate equivalent to 4 mg of ixazomib (as 5.7 mg of ixazomib citrate).
Excipients/Inactive Ingredients: NINLARO 2.3 mg hard capsule: The other ingredients are: In the capsule: microcrystalline cellulose, magnesium stearate and talc.
The capsule shell contains: gelatin, titanium dioxide (E171) and red iron oxide (E172).
The printing ink contains: shellac, propylene glycol, potassium hydroxide, and black iron oxide (E172).
NINLARO 3 mg hard capsule: The other ingredients are: In the capsule: microcrystalline cellulose, magnesium stearate and talc.
The capsule shell contains: gelatin, titanium dioxide (E171) and black iron oxide (E172).
The printing ink contains: shellac, propylene glycol, potassium hydroxide, and black iron oxide (E172).
NINLARO 4 mg hard capsule: The other ingredients are: In the capsule: microcrystalline cellulose, magnesium stearate and talc.
The capsule shell contains: gelatin, titanium dioxide (E171), yellow iron oxide (E172) and red iron oxide (E172).
The printing ink contains: shellac, propylene glycol, potassium hydroxide, and black iron oxide (E172).